TABLE 1.
Variable | Mean | SD | Range |
---|---|---|---|
| |||
MRI quantitative measurements | |||
Volume (mL) | 2379.0 | 696.9 | 812–4693 |
Stiffness (kPa)a | 2.7 | 0.6 | 1.5–5.5 |
Fat fraction (%)b | 14.5 | 10.3 | 0.7–39.0 |
Histopathologic scores | |||
Steatosis (0–3) | 2.0 | 0.9 | 0–3 |
Lobular inflammation (0–3) | 1.2 | 0.7 | 0–3 |
Portal inflammation (0–2) | 0.8 | 0.6 | 0–2 |
Hepatocyte ballooning (0–2) | 0.7 | 0.6 | 0–2 |
Fibrosis stage (0–4) | 1.0 | 1.1 | 0–4 |
NAFLD score (0–8) | 3.8 | 1.6 | 0–7 |
Liver stiffness was measured in only 68 patients.
MRI examinations performed between January and December 2012 did not routinely include a liver fat fraction measurement; thus, fat fraction was measured in only 55 patients.